miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

被引:0
作者
Y Iwagami
H Eguchi
H Nagano
H Akita
N Hama
H Wada
K Kawamoto
S Kobayashi
A Tomokuni
Y Tomimaru
M Mori
Y Doki
机构
[1] Graduate School of Medicine,Department of Surgery
[2] Osaka University,undefined
来源
British Journal of Cancer | 2013年 / 109卷
关键词
microRNA; miR-320c; pancreatic cancer; gemcitabine resistance; SMARCC1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:502 / 511
页数:9
相关论文
共 538 条
[1]  
Ahn J(2011)Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expression Oncogene 30 445-456
[2]  
Ko M(2009)Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma Oncogene 28 2903-2909
[3]  
Lee C(2010)Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF Cancer Res 70 3606-3617
[4]  
Kim J(2009)Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer Br J Cancer 100 511-523
[5]  
Yoon H(2012)Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 Nat Cell Biol 14 159-167
[6]  
Seong RH(2009)The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma J Hepatol 50 358-369
[7]  
Akita H(2009)Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer Cancer Res 69 1407-1415
[8]  
Zheng Z(2010)Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines Eur J Cancer 46 2771-2780
[9]  
Takeda Y(2004)An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines Cancer Res 64 3761-3766
[10]  
Kim C(2011)Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene Epigenetics 6 1444-1453